Focalin Sales May Be Weak...But It Won't Hurt This Stock By: Benzinga via Benzinga October 10, 2015 at 12:45 PM EDT IntelliPharmaCeutics Intl Inc (USA) (NASDAQ: IPCI) shares are down 48 percent year-to-date, plunging in August, and continuing a ... Read More >> Related Stocks: Intellipharmaceutics